Book your luxury accommodation at Buenos Aires Hilton Hotel with preferential rates

hilton solaciWe want your participation at SOLACI-CACI 2017 to be a whole, fulfilling experience, one to combine not only the fruitful exchange with colleagues or the acquisition of new scientific knowledge, but also the comfort of feeling home.

This is why we offer all SOLACI-CACI 2017 attendees and exhibitors the chance to stay at one the most luxurious and reputed hotels in Buenos Aires: the Hilton.

In addition to the benefit of staying at the Congress venue, SOLACI offers to book your room at preferential rates: instead of USD 269 + VAT the room without breakfast, you will pay USD 209 + VAT and breakfast included.

We invite you to book your room

HERE

 

For reservations in other hotels, contact the tourism agency

Argentina Travel Group
WEB SITE
+5411 4813-9763
andrea@atg-evt.com.ar

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....